参考文献/References:
[1] Ray I, Mahata SK, De RK. Obesity: an immunometabolic perspective[J]. Front Endocrinol(Lausanne),2016,7:157. DOI:10.3389/fendo.2016.00157.
[2] Parvaresh Rizi E, Baig S, Shabeer M,et al. Meal rich in carbohydrate, but not protein or fat, reveals adverse immunometabolic responses associated with obesity[J].Nutr J,2016,15(1):100. DOI:10.1186/s12937-016-0219-0.
[3] Mace EM, Orange JS. Genetic causes of human NK cell deficiency and their effect on NK cell subsets[J].Front Immunol,2016,7:545. DOI:10.3389/fimmu.2016.00545.
[4] Joshi N, Caputo GM, Weitekamp MR,et al. Infections in patients with diabetes mellitus[J].N Engl J Med,1999,341(25):1906-1912. DOI:10.1056/NEJM199912163412507.
[5] Fakhruddin S, Alanazi W, Jackson KE. Diabetes-induced reactive oxygen species: mechanism of their generation and role in renal injury[J].J Diabetes Res,2017,2017:8379327. DOI:10.1155/2017/8379327.
[6] Francisco CO, Catai AM, Moura-Tonello SC,et al. Cytokine profile and lymphocyte subsets in type 2 diabetes[J].Braz J Med Biol Res,2016,49(4):e5062. DOI:10.1590/1414-431X20155062.
[7] Piatkiewicz P, Miek T, Bernat-Karpińska M,et al. The dysfunction of NK cells in patients with type 2 diabetes and colon cancer[J].Arch Immunol Ther Exp(Warsz),2013,61(3):245-253. DOI:10.1007/s00005-013-0222-5.
[8] Piatkiewicz P, Bernat-Karpińska M, Miek T,et al. NK cell count and glucotransporter 4(GLUT4)expression in subjects with type 2 diabetes and colon cancer[J].Diabetol Metab Syndr,2016,8:38. DOI:10.1186/s13098-016-0152-6.
[9] Xia C, Rao X, Zhong J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation[J].J Diabetes Res,2017,2017:6494795.DOI:10.1155/2017/6494795.
[10] Berrou J, Fougeray S, Venot M,et al. Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes[J].PLoS One,2013,8(4):e62418. DOI:10.1371/journal.pone.0062418.
[11] van der Pouw Kraan TC, Chen WJ, Bunck MC,et al. Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity[J].BMC Med Genomics,2015,8:20. DOI:10.1186/s12920-015-0096-y.
[12] Kumar NP, Sridhar R, Nair D,et al. Type 2 diabetes mellitus is associated with altered CD8(+)T and natural killer cell function in pulmonary tuberculosis[J].Immunology,2015,144(4):677-686. DOI:10.1111/imm.12421.
[13] Kumar NP, Moideen K, George PJ,et al. Impaired cytokine but enhanced cytotoxic marker expression in mycobacterium tuberculosis-induced CD8+ T cells in individuals with type 2 diabetes and latent mycobacterium tuberculosis infection[J].J Infect Dis,2016,213(5):866-870. DOI:10.1093/infdis/jiv484.
[14] Rodriguez Camargo DC, Tripsianes K, Buday K, et al. The redox environment triggers conformational changes and aggregation of hIAPP in type Ⅱ Diabetes[J].Sci Rep,2017,7:44041.DOI:10.1038/srep44041.
[15] Berrou J, Fougeray S, Venot M,et al. Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes[J].PLoS One,2013,8(4):e62418. DOI:10.1371/journal.pone.0062418.
[16] Lee BC, Kim MS, Pae M,et al. Adipose natural killer cells regulate adipose tissue macrophages to promote insulin resistance in obesity[J].Cell Metab,2016,23(4):685-698. DOI:10.1016/j.cmet.2016.03.002.
[17] O'Rourke RW, Meyer KA, Neeley CK,et al. Systemic NK cell ablation attenuates intra-abdominal adipose tissue macrophage infiltration in murine obesity[J].Obesity(Silver Spring),2014,22(10):2109-2114. DOI:10.1002/oby.20823.
[18] Lee BC, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance[J].Biochim Biophys Acta,2014,1842(3):446-462. DOI:10.1016/j.bbadis.2013.05.017.
[19] Wensveen FM, Jelencˇ ic' V, Valentic' S,et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance[J].Nat Immunol,2015,16(4):376-385. DOI:10.1038/ni.3120.
[20] Mir M, Rostami A, Hormozi M. Comparison of serum levels of IL-18 in peripheral blood of patients with type Ⅱ diabetes with nephropathy clinical protests and patients with type Ⅱ diabeteswithout nephropathy clinical protests[J].Diabetes Metab Syndr,2016, pii: S1871-4021(16)30171-0. DOI:10.1016/j.dsx.2016.08.018.
[21] Bonaccorsi I, De Pasquale C, Campana S,et al. Natural killer cells in the innate immunity network of atherosclerosis[J].Immunol Lett,2015,168(1):51-57. DOI:10.1016/j.imlet.2015.09.006.
[22] Medeiros MC, Frasnelli SC, Bastos Ade S,et al. Modulation of cell proliferation, survival and gene expression by RAGE and TLR signaling in cells of the innate and adaptive immune response: role of p38 MAPK and NF-κB[J].J Appl Oral Sci,2014,22(3):185-193.
相似文献/References:
[1]曾静波,王姮.2型糖尿病与自身免疫反应[J].国际内分泌代谢杂志,2007,(04):259.
[2]朱素君,谢锦桃,刘军,等.二甲双胍:2型糖尿病治疗的基础药[J].国际内分泌代谢杂志,2007,(04):280.
[3]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
[4]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(04):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
[5]赵丽娟,徐宽枫,杨涛,等.SLC30A8和PTPRD基因多态性与南京地区中老年人群2型糖尿病的相关性研究[J].国际内分泌代谢杂志,2015,(03):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
Zhao Lijuan*,Xu Kuanfeng,Yang Tao,et al.Relationship between SLC30A8 and PTPRD gene polymorphisms and type 2 diabetes in middle aged and elderly people in Nanjing area[J].International Journal of Endocrinology and Metabolism,2015,(04):145.[doi:10.3760/cma.j.issn.1673-4157.2015.03.001]
[6]王洁,何媛,于珮.糖尿病肾病的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
Wang Jie*,He Yuan,Yu Pei..Risk factors of diabetic nephropathy[J].International Journal of Endocrinology and Metabolism,2015,(04):153.[doi:10.3760/cma.j.issn.1673-4157.2015.03.003]
[7]刘帅,张萍,方毅,等.2型糖尿病合并无症状冠状动脉钙化的相关危险因素分析[J].国际内分泌代谢杂志,2015,(03):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
Liu Shuai*,Zhang Ping,Fang Yi,et al.Analysis of the risk factors related with asymptomatic coronary calcification for type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2015,(04):158.[doi:10.3760/cma.j.issn.1673-4157.2015.03.004]
[8]徐庆海,马颖,李铁马.2型糖尿病患者高甘油三酯血症-腰围表型与甲状腺功能异常的关系[J].国际内分泌代谢杂志,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
Xu Qinghai,Ma Ying,Li Tiema..Association of hypertriglyceridaemic-waist phenotype with thyroid dysfunction in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):222.[doi:10.3760/cma.j.issn.1673-4157.2015.04.002]
[9]潘道延,沈洁,朱筱,等.利格列汀对2型糖尿病大鼠代谢性内毒素血症的影响[J].国际内分泌代谢杂志,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
Pan Daoyan,Shen Jie,Zhu Xiao,et al.Effects of linagliptin on metabolic endotoxemia in type 2 diabetic rats[J].International Journal of Endocrinology and Metabolism,2015,(04):230.[doi:10.3760/cma.j.issn.1673-4157.2015.04.004]
[10]黄桥,白洁,杜洪泉.一种新的脂肪细胞因子——cartonectin[J].国际内分泌代谢杂志,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]
Huang Qiao*,Bai Jie,Du Hongquan..A novel adipokine--cartonectin[J].International Journal of Endocrinology and Metabolism,2015,(04):265.[doi:10.3760/cma.j.issn.1673-4157.2015.04.014]